Substantial in vivo tumour growth suppression with low toxicity; downregulated nuclear factor-κB and BCL-2 expression; inhibited expression of P-glycoprotein, MrP-1, BCRP, and triggered apoptosis. The gene discussed is ABCG2; the disease is neoplasm.